56
https://pubmed.ncbi.nlm.nih.gov/38117205
This study has developed a high-performance plasma biomarker panel using an ultrasensitive biosensing system for Alzheimer’s disease screening, achieving an area under the curve of over 0.94 in the receiver operator characteristic curve.